Marcia Belvin

Insider Reports History

Entity
Individual
Location
C/O Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Ste. 400, South San Francisco, CA
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Marcia Belvin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marcia Belvin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. SVP, Chief Scientific Officer Common Stock 176K $216K $1.23 Aug 20, 2024 Direct
CytomX Therapeutics, Inc. SVP, Chief Scientific Officer Performance Stock Units (PSUs) 0 $0 $1.23 Aug 20, 2024 Direct
CytomX Therapeutics, Inc. SVP, Chief Scientific Officer Stock Option (Right to Buy) 123K Jan 18, 2024 Direct

Insider Reports Filed by Marcia Belvin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTMX CytomX Therapeutics, Inc. Aug 20, 2024 3 -$5.14K 4 Aug 22, 2024 SVP, Chief Scientific Officer
CTMX CytomX Therapeutics, Inc. Mar 19, 2024 1 -$26.7K 4 Mar 21, 2024 SVP, Chief Scientific Officer
CTMX CytomX Therapeutics, Inc. Jan 18, 2024 3 $0 4 Jan 19, 2024 SVP, Chief Scientific Officer
CTMX CytomX Therapeutics, Inc. Dec 20, 2023 1 -$5.63K 4 Dec 22, 2023 SVP, Chief Scientific Officer
CTMX CytomX Therapeutics, Inc. Dec 17, 2023 2 $0 4 Dec 19, 2023 SVP, Chief Scientific Officer
CTMX CytomX Therapeutics, Inc. Sep 20, 2023 2 -$5.36K 4 Sep 22, 2023 SVP, Chief Scientific Officer
CTMX CytomX Therapeutics, Inc. Mar 22, 2023 1 $0 4 Mar 29, 2023 SVP, Chief Scientific Officer
CTMX CytomX Therapeutics, Inc. Mar 22, 2023 0 $0 3 Mar 29, 2023 SVP, Chief Scientific Officer